Global Diabetes Diagnostics Industry

  • April 2012
  • -
  • Global Industry Analysts
  • -
  • 492 pages

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ Million by the following Product Segments: Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit, & Diabetes Tracking System), and Diabetes Testing Supplies (Blood Glucose Test Strips, Lancet, Lancet Device, Reagent Strip, & Others (Include Blood Glucose Sensors, Control Solution, and Reagent Tablets). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Abbott Diabetes Care, Bayer Diabetes Care, Bio-Rad Laboratories, Nipro Diagnostics, Inc., LifeScan, Inc., Medtronic MiniMed, Inc., Roche Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-3
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Blood Glucose Testing Devices I-4
Blood Glucose Monitor I-4
Diabetes Kit I-4
Diabetes Tracking System I-4
Blood Glucose Sensor I-4
Diabetes Testing Supplies I-4
Blood Glucose Test Strips I-4
Lancet I-5
Lancet Device I-5
Reagent Strips I-5


II. EXECUTIVE SUMMARY

1. MARKET OUTLOOK II-1
Increasing Diabetes Prevalence - A Major Growth Propeller II-1
Table 1: Worldwide Diabetes Market (2000 and 2025): Percentage
Breakdown of Diabetes Incidence by Region - India, China,
Brazil, Russia and Others (includes corresponding
Graph/Chart) II-1
Diabetics Cut Back Spending on Disease Management during
Recession, Market Recovers from 2010 II-2

2. MARKET DYNAMICS AND TRENDS II-3
Major Pharma Players - Focusing on Diabetes Diagnostics II-3
Growing Emphasis on Technological Integration in Diabetes Market II-3
Outlook Bright for Blood Glucose Meters and Strips II-3
Self Monitoring of Blood Glucose on the Rise II-4
Trends in the Glucose Meter/Monitoring Systems II-4
Focus on Established Procedures Driving Growth II-4
Portable Glucose Meters Fast Replacing Conventional Testing
Methods II-4
Point-of-Care Testing - A Profitable Venture II-5
It Pays to be Customer Focused in a Mature Market II-5
Advancements in Glucose Monitoring Devices - A New Ray of Hope II-5
Pain-Free and Alternate-Site Glucose Monitoring II-5
Continuous Glucose Monitoring II-6
Up-to-the-Minute Monitoring II-6
Medicare Coverage - A Strong Positive II-6

3. COMPETITION II-7
Self-Monitoring/Household Blood Glucose - Spearheading Growth II-7
Table 2: Global Household Blood Glucose Monitoring Device
Market (2011): Percentage Market Share Breakdown by Leading
Players (includes corresponding Graph/Chart) II-7

4. TRENDS IN DIABETES MANAGEMENT II-8
Recent Advancements in Diabetes Management II-8
New Developments II-8
Recent Advancements in Diabetes Therapy II-8
Aldose Reductase Inhibitors (ARI) II-8
Advanced Glycation End-Product Inhibitors (AGEI) II-8
Rising Awareness of Diabetes II-9
Insulin Delivery Systems - A Potential High Growth Segment II-9
Innovations in Insulin Delivery II-9
Advances in Insulin Delivery - A Review II-10
Pulmonary Insulin Delivery II-10
Jet Injection II-11
Ultrasonic Transdermal-Patch Technology II-11
Insulin Delivery via Mouth Spray II-11
Artificial Pancreas Technology II-11
Increased Incidence of Diabetes Among HIV+ II-12

5. TECHNOLOGICAL TRENDS II-14
Innovative Product Design Developments Enhance Diabetic’s
Quality of Life II-14
Reducing Costs for Managed Care Service Providers - Emerging
Trend II-14
Finding Solutions Through Innovations II-14

6. BLOODLESS TESTING - AN OVERVIEW II-16
Non-invasive Blood Glucose Testing - Still in Experimental Stage II-16
High Price - A Major Hurdle II-16

7. A PEEK INTO OTC/PHYSICIANS’ OFFICE DIABETES TESTS MARKET II-17
In-home Tests: Making Health Control Easier II-17
Common OTC Tests II-17
Glucose Monitor II-17
Cholesterol II-17
Major Market Segments in OTC/Physicians’ Office Diabetes Tests II-17
Urine Strips II-18
Blood Glucose Strips: A Well Established Market II-18
Blood Glucose Meters II-19
PBGM Devices: Based on Photometric or Biosensor Technology II-20

8. LABORATORY DIABETES TESTS MARKET - A PRIMER II-21
Various Types of Laboratory Diabetes Tests II-21
Blood Glucose and Related Tests II-21
Fructosamine Tests: To Diagnose Gestational Diabetes II-21
Glycosylated Hemoglobin Tests: A Promising Approach in
Diagnosing Diabetes Mellitus II-21
Glycosylated Haemoglobin Tests - Paving Way for Early Stage
Diabetes Diagnosis II-22
Immunoassays (Anti-Insulin and Anti-Islet Antibodies) II-22
It Pays to Introduce Advanced Instruments II-22
Urine Ketones and Microalbuminuria: To Test Type I Diabetes II-23
Diabetic Renal Disease with Reference to Microalbuminuria II-23
All Other Diabetes Tests II-23
Diabetes Tests II-23
Fasting Plasma Glucose Test II-23
Casual Glucose Test II-23

9. DIABETES DIAGNOSTICS - AN OVERVIEW II-24
Cost - The Ultimate Factor in the Choice of Blood Glucose
Monitoring Systems II-24
Classification II-24
Blood Glucose Testing Devices II-25
Blood Glucose Monitor/Meter II-25
Select Blood Glucose Meters Based on Test Strips II-25
Diabetes Kit II-26
Diabetes Tracking System II-26
Blood Glucose Sensor II-26
Diabetes Testing Supplies II-26
Blood Glucose Test Strips II-26
Lancet II-26
Lancet Device II-26
Reagent Strips II-27
Reagent Tablet II-27

10. DIABETES: A CHRONIC BODY DISORDER II-28
Diabetes Symptoms II-28
Diabetes: One of the Leading Causes of Death in Developed
Countries II-28
Types of Diabetes II-29
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM) II-29
Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (
NIDDM) II-30
NIDDM Might Lead to Cardiovascular Complications II-30
Increasing Occurrence of Type II Diabetes Worldwide II-30
Factors Influencing Type 2 diabetes II-31
Agents Used for Type 2 Diabetes Treatment II-31
Diabetes: A Major Healthcare Challenge II-31
Etiological Factors Causing Diabetes II-32
Insulin Types II-32
Diabetes-Related Complications II-32
Complications Associated with Diabetes - In a Nutshell II-33
Heart Disease II-33
Stroke II-34
High Blood Pressure II-34
Blindness II-34
Kidney Disease II-34
Nerve Disease II-34
Amputations II-34
Dental Disease II-34
Pregnancy II-34
Possible Complications of Diabetes II-34
Microvascular Complications (Small Blood Vessel Damage) II-34
Macrovascular Complications (Large Blood Vessel Damage) II-35
Other Complications II-35
Microvascular Complications (Small Blood Vessel Damage) II-35
Retinopathy II-35
Diabetic Neuropathy II-35
Nephropathy II-35
Macrovascular Complications (Large Blood Vessel Damage) II-36
Cardiac Problems II-36
Hypertension (High Blood Pressure) II-36
Other Major Complications II-36
Infections II-36
Impotence II-36
Pregnancy Complications II-36
Other Complications Resulting from Diabetes II-36
Obesity II-36
Obsessive Compulsive Disorder II-37
Foot Ulcers II-37
Dementia and its Association with Diabetes II-37
Hypoglycemia II-37
Diabetic Ketoacidosis II-38
Undiagnosed Diabetics: More Prone to Cardiovascular Diseases II-39

11. DIABETES INCIDENCE AND PREVALENCE II-40
Table 3: Worldwide Prevalence of Diabetes Mellitus by Region:
2010 and 2030 (includes corresponding Graph/Chart) II-40
Diabetes Mellitus Cases Worldwide - A Demographic Analysis by
Geographic Region II-41
North America II-41
United States II-41
Canada II-41
Mexico II-41
Table 4: Prevalence of Diabetes Mellitus in North America
(2010 and 2030): Breakdown by Country, Age Group, and Gender
(In Thousand People and %) (includes corresponding
Graph/Chart) II-41
Europe II-42
Table 5: Prevalence of Diabetes Mellitus in Europe (2010 and
2030): Breakdown by Country, Age Group, and Gender (In
Thousand People and %) II-42
Asia-Pacific II-43
Southeast Asian Region II-43
Western Pacific Region II-43
Table 6: Prevalence of Diabetes Mellitus in South East Asia
(2010 and 2030): Breakdown by Country, Age Group, and Gender
(In Thousand People and %) (includes corresponding
Graph/Chart) II-44

Table 7: Prevalence of Diabetes Mellitus in Western Asia
(2010 and 2030): Breakdown by Country, Age Group, and Gender
(In Thousand People and %) (includes corresponding
Graph/Chart) II-45
South and Central America II-46
Type-1 Diabetes II-46
Type-2 Diabetes II-46
Table 8: Prevalence of Diabetes Mellitus in South and Central
America (2010 and 2030): Breakdown by Country, Age Group, and
Gender (In Thousand People and % II-47
Rest of World II-48
Table 9: Prevalence of Diabetes Mellitus in Africa (2010 and
2030): Breakdown by Country, Age Group, and Gender (In
Thousand People and %) II-48

Table 10: Prevalence of Diabetes Mellitus in The Middle East
and North Africa (2010 and 2030): Breakdown by Country, Age
Group, and Gender (In Thousand People and %) (includes
corresponding Graph/Chart) II-49

12. PRODUCT INTRODUCTIONS/INNOVATIONS II-50
LifeScan Introduces New System for Testing Blood Glucose II-50
Bayer Diabetes Care Launches Blood Glucose Meter II-50
Bayer Introduces CONTOUR(R) USB II-50
Roche Diagnostics Unveils Accu-Check Mobile Device in the UK II-51
ARKRAY Unveils New Assure® Pro Blood Glucose Monitoring Strip II-51
TRCL and Entra Health Systems Introduce AmCare Cell Phone
Supported Diabetes Management Services II-51
Home Diagnostics Announces the US Launch of TRUE2go Blood
Glucose Monitor II-52
AgaMatrix Launches Kroger BGM II-52
ARKRAY Obtains FDA Approval for GLUCOCARD® Vital™ BGM II-52
Bayer Receives FDA Approval for Marketing CONTOUR USB II-52
Medtronic Rolls Out Paradigm Veo II-53
Home Diagnostics Introduces TRUEmanagerTM Diabetes Management
Software II-53
Fora Care to Introduce Affordable Diabetes Care Solutions II-54
Roche Diagnostics Introduces Accu-Chek Smart Pix II-54
Entra Launches MyGlucoHealth Meter in the US II-54
ACON Unveils On Call® Plus Blood Glucose Monitoring System in US II-55

13. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE
BUILDER II-56
Arkray and Piramal Introduce Advanced Glucocard 01 II-56
BodyTel Scientific to Introduce GlucoTel System II-56
Bio-Rad Launches Liquichekâ„¢ Diabetic Control II-57
Home Diagnostics Introduces TRUEread II-57
Medtronic’s CGMS® iPro™ Receives FDA Approval II-57
Siemens Introduces the DCA Vantageâ„¢ Analyzer II-57
Arkray Introduces Analyzers for Diabetes Testing II-58
Bayer Releases Brio® and Breeze® Diabetes Management Systems
in South Korea and China II-58
GenExel-Sein Introduces DUO-CAREâ„¢ Home-Use Diabetes Products II-58
HemoCue Unveils New Testing System for Point of Care Use II-58
LifeScan Launches Easy-to-Use Glucose Meter II-58
Roche Rolls Out ACCU-CHEK® Spirit Insulin Pump System II-59
Novo Nordisk Introduces Simple-to Use GlucaGen® HypoKit™ II-59
Biomerica Launches New Diabetes Diagnostic Test II-59
Hypoguard Introduces New Glucose Meter II-60
Bio-Rad Launches VARIANTâ„¢ II TURBO Monitoring System II-60
Roche Launches Accu-Chek Go for Blood Glucose Monitoring II-60
Roche Diagnostics Launches Accu-Chek Lancing System II-60
LifeScan Introduces Glucose Meter in India II-60
Abbott Laboratories Introduces Two New Glucose Meters in Europe II-60
HDI Launches KetoCareâ„¢ Ketone Test Strips II-61
Roche Diagnostics Unveils Accu-Chek D-TRON Plus II-61
Abbott Introduces Precision Xtraâ„¢ Advanced Diabetes Management
System II-61
Abbott Diabetes Care Launches Precision Xtraâ„¢ Blood Glucose
Test Strip II-61
LifeScan Introduces Onetouch Horizon II-61
Bayer Diagnostics Unveils Ascensia® CONTOUR™ Blood Glucose
Monitoring System II-61

14. RECENT INDUSTRY ACTIVITY II-62
Home Diagnostics and Nipro Diabetes to Merge to Form Nipro
Diagnostics II-62
IVAX Diagnostics Inks Product Distribution Agreement with
Biomerica II-62
Terumo Spins-Off Diabetes Business II-62
Premier Inks Alliance with Healthcare Companies II-62
AgaMatrix and Sanofi-Aventis to Co-Develop Blood Glucose
Monitoring Solutions II-63
Nippon Product Merges with Home Diagnostics II-63
PositiveID Purchases Assets and Intellectual Property Rights
of Easy Check II-63
Sanvita CBGM Acquires Assets of Sanvita II-63
ARKRAY Secures FDA 510k Clearance for Assure® Platinum II-64
Brazos Subsidiary to Merge with Epinex II-64

15. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-65
Neighborhood Diabetes Takes Over New York Diabetic Supply II-65
Home Diagnostics Enters into an Exclusive Supply Deal with
Rite Aid Pharmacy Chain II-65
OPG Acquires Hahn and Hahn II-65
Nanobac Agrees to Acquire DNAPrint Genomics II-65
Novo Nordisk’s RandD Plans in India II-66
Medco Health Solutions Announces Acquisition of PolyMedica II-66
PolyMedica Takes over QualityCare II-66
NationsHealth Acquires Diabetes Care and Education II-66
Inverness Acquires Cholestech II-66
WaveSense Launches European Subsidiary II-67
XMDC, Diabetes Detection Sign on Distribution Agreement II-67
IQMC Agrees on Acquisition of Lifecare AS II-67
Bayer’s Contour TS Test Strip Market Recall II-67
BBI Acquires CDx and Audiometrics II-67
Bayer Receives Ease-Of-Use Commendation for Ascensia® BREEZE®
Blood Glucose Monitoring System II-68
BYETTA® (exenatide) Receives Marketing Authorization from
European Commission II-68
Bayer Diabetes Care Acquires Metrika II-68
BD Walks Out of BGM Market II-68
Bio-Rad Acquires Provalis’ Medical Diagnostics Division II-68
Bio-Rad Inks Multi-Year Agreement with Premier II-69
Cholestech and Life Line Collaborate Over Diagnostic Testing II-69
FDA Approves Medtronic’s MiniMed Paradigm® RT CGM System II-69
FDA Clears Abbott’s FreeStyle® Freedom™ Blood Glucose Meter II-69
FDA Approves Hypoguard’s Blood Glucose Monitor II-69
FDA Approves DexCom’s Continuous Glucose Monitoring System II-70
Johnson and Johnson Acquires Animas Corporation II-70
LifeScan and NIR Agree on Extension of First Option Agreement II-70
Pfizer Obtains Global Rights to Inhalable Human Insulin -
Exubera® II-70
Roche Receives FDA Clearance for Acu-Check Insulin Pump II-70
Sphere Medical and Analogic Team up for Monitoring Solutions II-71
NeuroMetrix Wins Exclusive Marketing License of DigiScope II-71
FDA Recommends Exubera® for Diabetic Patients II-71
Bio-Rad and Sysmex Ink Co-Marketing Agreement II-71
Diabetes Gold Forms Joint Venture with BioTex Labs II-71
FDA Grants 510(k) Clearance for Abbott’s Freestyle Connect™
Blood Glucose Meter II-72
FDA Clears Hypoguard’s Advance Micro-draw™ Blood Glucose System II-72
FDA Approves Home Diagnostics’ Blood Glucose Testing System II-72
Insulet Corporation and Solectron Collaborate to Develop OmniPodâ„¢ II-72
PolyMedica Acquires National Diabetic Pharmacies II-73
Cygnus, Inc. Divests its Glucose-Monitoring Assets II-73
Home Diagnostics’ Blood Glucose Monitor Features in Best Rx
Value Drug List of Ohio II-73
Roche Diagnostics Receives US FDA Approval for its Latest
Blood Glucose Meter II-73
Provalis Ships in2it A1C to US II-73
Hitachi Develops Unique Non-Invasive Device for Diabetes
Monitoring II-73
Bayer Diagnostics Business Splits into Two Units II-74
Abbott Laboratories Acquires TheraSense Inc. II-74
Roche Acquires Infusion Systems Division of Disetronic II-74
Bristol-Myers Squibb Enters into Alliance with Merck II-74
Provalis Receives FDA Approval II-74
Gunze Enters into an Agreement with Sanko Junyaku Strike II-75
Health Hero Network Receives US FDA Approval II-75
Roche Diagnostics Corporation Receives Contract from Premier Inc II-75
Vitro Introduces Stem Cell Therapy for Diabetes II-75
Home Diagnostics’ Blood Glucose Monitor Features in RxAmerica
National Formulary II-75
Home Diagnostics’ Blood Glucose Monitor Features in Procare Rx
National Formulary II-75
Medtronic Receives FDA Approval for its New Continuous Glucose
Monitoring System II-76
Roche Diagnostics Awarded Blood Glucose and Lancet Contracts II-76
HDI’s TrueTrack Smart System Wins FDA Approval for AST II-76
Seradyn Bags US FDA Clearance for HbA1c Assay II-76
Bristol-Myers Squibb Receives Exclusive Rights to AlcNow
Diabetes Monitor II-77
Bio-Rad Laboratories Awarded 510(k) Clearance for VARIANTâ„¢ II
TURBO II-77

16. FOCUS ON SELECT GLOBAL PLAYERS II-78
Abbott Diabetes Care (US) II-78
Bayer Diabetes Care (US) II-78
Bio-Rad Laboratories (US) II-78
Nipro Diagnostics, Inc. (US) II-79
LifeScan, Inc. (US) II-79
Medtronic MiniMed, Inc. (US) II-79
Roche Diagnostics (Switzerland) II-80
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan) II-80
Siemens Healthcare Diagnostics (US) II-80

17. GLOBAL MARKET PERSPECTIVE II-82
Table 11: World Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-82

Table 12: World Historic Review for Diabetes Diagnostics by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-83

Table 13: World 15-Year Perspective for Diabetes Diagnostics
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-84

Table 14: World Recent Past, Current and Future Analysis for
Blood Glucose Testing Devices by Geographic Region/Country -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-85

Table 15: World Historic Review for Blood Glucose Testing
Devices by Geographic Region/ Country - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-86

Table 16: World 15-Year Perspective for Blood Glucose Testing
Devices by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-87

Table 17: World Recent Past, Current and Future Analysis for
Blood Glucose Testing Devices by Product Segment - Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-88

Table 18: World Historic Review for Blood Glucose Testing
Devices by Product Segment - Blood Glucose Test Kit, Blood
Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking
System Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-89

Table 19: World 15-Year Perspective for Blood Glucose Testing
Devices by Product Segment - Percentage Breakdown of Dollar
Sales for Blood Glucose Test Kit, Blood Glucose Meter/Monitor,
Diabetes Kit, and Diabetes Tracking System Markets for Years
2003, 2011, and 2017 (includes corresponding Graph/Chart) II-90

Table 20: World Recent Past, Current and Future Analysis for
Blood Glucose Test Kits by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-91

Table 21: World Historic Review for Blood Glucose Test Kits by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-92

Table 22: World 15-Year Perspective for Blood Glucose Test
Kits by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-93

Table 23: World Recent Past, Current and Future Analysis for
Blood Glucose Meters/Monitors by Geographic Region/ Country -
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-94

Table 24: World Historic Review for Blood Glucose Meters/
Monitors by Geographic Region/ Country - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-95

Table 25: World 15-Year Perspective for Blood Glucose
Meters/Monitors by Geographic Region - Percentage Breakdown of
Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets for
Years 2003, 2011 and 2017 (includes corresponding Graph/Chart) II-96

Table 26: World Recent Past, Current and Future Analysis for
Diabetes Kits by Geographic Region/Country - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-97

Table 27: World Historic Review for Diabetes Kits by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-98

Table 28: World 15-Year Perspective for Diabetes Kits by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-99

Table 29: World Recent Past, Current and Future Analysis for
Diabetes Tracking Systems by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-100

Table 30: World Historic Review for Diabetes Tracking Systems
by Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-101

Table 31: World 15-Year Perspective for Diabetes Tracking
Systems by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-102

Table 32: World Recent Past, Current and Future Analysis for
Diabetes Testing Supplies by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-103

Table 33: World Historic Review for Diabetes Testing Supplies
by Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-104

Table 34: World 15-Year Perspective for Diabetes Testing
Supplies by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-105

Table 35: World Recent Past, Current and Future Analysis for
Diabetes Testing Supplies by Product Segment - Blood Glucose
Test Strips, Lancet, Lancet Device, and Reagent Strip Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-106

Table 36: World Historic Review for Diabetes Testing Supplies
by Product Segment - Blood Glucose Test Strips, Lancet, Lancet
Device, and Reagent Strip Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) II-107

Table 37: World 15-Year Perspective for Diabetes Testing
Supplies by Product Segment - Percentage Breakdown of Dollar
Sales for Blood Glucose Test Strips, Lancet, Lancet Device,
and Reagent Strip Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-108

Table 38: World Recent Past, Current and Future Analysis for
Blood Glucose Test Strips by Geographic Region/Country - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin
America and Rest of World Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2009 through
2017 (includes corresponding Graph/Chart) II-109

Table 39: World Historic Review for Blood Glucose Test Strips
by Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-110

Table 40: World 15-Year Perspective for Blood Glucose Test
Strips by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Latin America and Rest of World Markets for Years
2003, 2011 and 2017 (includes corresponding Graph/Chart) II-111

Table 41: World Recent Past, Current and Future Analysis for
Lancets by Geographic Region/ Country - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Latin America and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-112

Table 42: World Historic Review for Lancets by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-113

Table 43: World 15-Year Perspective for Lancets by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) II-114

Table 44: World Recent Past, Current and Future Analysis for
Lancet Devices by Geographic Region/Country - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-115

Table 45: World Historic Review for Lancet Devices by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-116

Table 46: World 15-Year Perspective for Lancet Devices by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-117

Table 47: World Recent Past, Current and Future Analysis for
Reagent Strips by Geographic Region/Country - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-118

Table 48: World Historic Review for Reagent Strips by
Geographic Region/Country - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-119

Table 49: World 15-Year Perspective for Reagent Strips by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-120

Table 50: World Recent Past, Current and Future Analysis for
Other Diabetes Diagnostic Products/Supplies by Geographic
Region/Country - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-121

Table 51: World Historic Review for Other Diabetes Diagnostic
Products/Supplies by Geographic Region/ Country - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-122

Table 52: World 15-Year Perspective for Other Diabetes
Diagnostic Products/Supplies by Geographic Region - Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Latin America and Rest of
World Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) II-123


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Glucose Monitoring Market Bounces Back, Post Recession III-1
Competitive Landscape III-1
Table 53: US Blood Glucose Monitoring Market (2011) :
Percentage Share Breakdown for Leading Brands (includes
corresponding Graph/Chart) III-1
Diabetes Prevalence in the US by Type III-2
Table 54: Diabetes Prevalence in the US by Type: 2008
(includes corresponding Graph/Chart) III-2
Diabetes: A Leading Cause of Death in the US III-2
Market Trends III-3
Companies Focus on Research for Better Diabetes Diagnostics III-3
Focus on Established Procedures Driving Growth III-3
Insulin Delivery Systems - A Potential High Growth Segment III-3
Competitive Landscape III-4
Roche Losing its Share in the US Blood Glucose Monitors
Market III-4
B.Market Analytics III-5
Table 55: The US Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-5

Table 56: The US Historic Review for Diabetes Diagnostics by
Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) III-6

Table 57: The US 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-7

2. CANADA III-8
A.Market Analysis III-8
Diabetes Incidence III-8
B.Market Analytics III-9
Table 58: Canadian Recent Past, Current and Future Analysis
for Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-9

Table 59: Canadian Historic Review for Diabetes Diagnostics
by Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/ Monitor, Diabetes
Kit, and Diabetes Tracking System) and Diabetes Testing
Supplies (Blood Glucose Test Strips, Lancet, Lancet Device,
And Reagent Strip) and Other Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2003
through 2008 (includes corresponding Graph/Chart) III-10

Table 60: Canadian 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) And Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-11

3. JAPAN III-12
A.Market Analysis III-12
Growing Aging Population Drives Diabetes Diagnostics Market III-12
Other Trends Influence Diabetes Diagnostics Market III-12
B.Market Analytics III-13
Table 61: Japanese Recent Past, Current and Future Analysis
for Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-13

Table 62: Japanese Historic Review for Diabetes Diagnostics
by Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2003 through
2008 (includes corresponding Graph/Chart) III-14

Table 63: Japanese 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-15

4. EUROPE III-16
A.Market Analysis III-16
Significant Increase in the Number of Diabetics III-16
B.Market Analytics III-17
Table 64: European Recent Past, Current and Future Analysis
for Diabetes Diagnostics by Geographic Region/Country -
France, Germany, Italy, UK and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-17

Table 65: European Historic Review for Diabetes Diagnostics
by Geographic Region/Country - France, Germany, Italy, UK
and Rest of Europe Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) III-18

Table 66: European 15-Year Perspective for Diabetes
Diagnostics by Geographic Region/Country - Percentage
Breakdown of Dollar Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2003, 2011 and 2017 (includes
corresponding Graph/Chart) III-19

Table 67: European Recent Past, Current and Future Analysis
for Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-20

Table 68: European Historic Review for Diabetes Diagnostics
by Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) III-21

Table 69: European 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-22

4a. FRANCE III-23
Market Analytics III-23
Table 70: French Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, And Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-23

Table 71: French Historic Review for Diabetes Diagnostics by
Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) Glucose Insta Glucose) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-24

Table 72: French 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-25

4b. GERMANY III-26
Market Analytics III-26
Table 73: German Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-26

Table 74: German Historic Review for Diabetes Diagnostics by
Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2003 through
2008 (includes corresponding Graph/Chart) III-27

Table 75: German 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-28

4c. ITALY III-29
Market Analytics III-29
Table 76: Italian Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-29

Table 77: Italian Historic Review for Diabetes Diagnostics
by Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2003 through
2008 (includes corresponding Graph/Chart) III-30

Table 78: Italian 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets for Years 2003, 2011 and 2017
(includes corresponding Graph/Chart) III-31

4d. THE UNITED KINGDOM III-32
Market Analytics III-32
Table 79: UK Recent Past, Current and Future Analysis for
Diabetes Diagnostics by Product Segment - Blood Glucose
Testing Devices (Blood Glucose Test Kit, Blood Glucose
Meter/Monitor, Diabetes Kit, and Diabetes Tracking System)
and Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2009 through 2017 (includes corresponding
Graph/Chart) III-32

Table 80: UK Historic Review for Diabetes Diagnostics by
Product Segment - Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,
and Diabetes Tracking System) and Diabetes Testing Supplies
(Blood Glucose Test Strips, Lancet, Lancet Device, and
Reagent Strip) and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Thousand for Years 2003 through
2008 (includes corresponding Graph/Chart) III-33

Table 81: UK 15-Year Perspective for Diabetes Diagnostics by
Product Segment - Percentage Breakdown of Dollar Sales for
Blood Glucose Testing Devices (Blood Glucose Test Kit, Blood
Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking
System) and Diabetes Testing Supplies (Blood Glucose Test
Strips, Lancet, Lancet Device, and Reagent Strip) and Other
Markets for Years 2003, 2011 and 2017 (includes corresponding
Graph/Chart) III-34

4e. REST OF EUROPE III-35
Market Analytics III-35
Table 82: Rest of European Recent Past, Current and Future
Analysis for Diabetes Diagnostics by Product Segment - Blood
Glucose Testing Devices (Blood Glucose Test Kit, Blood
Glucose Meter/Monitor, Diabetes Kit, and Diabetes Tracking
System) and Diabetes Testing Supplies (Blood Glucose Test
Strips, Lancet, Lancet Device, and Reagent Strip) and Other
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-35

Table 83: Rest of European Historic Review for Diabetes
Diagnostics by Product Segment - Blood Glucose Testing
Devices (Blood Glucose Test Kit, Blood Glucose Meter/
Monitor, Diabetes Kit, and Diabetes Tracking System) and
Diabetes Testing Supplies (Blood Glucose Test Strips,
Lancet, Lancet Device, and Reagent Strip) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-36

Table 84: Rest of European 15-Year Perspective for Diabetes
Diagnostics by Product Segment - Percentage Breakdown of
Dollar Sales for Blood Glucose Testing Devices (Blood
Glucose Test Kit, Blood Glucose Meter/Monitor, Diabetes Kit,

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Strategies for the Global Microbiology Testing Market” is a new seven-country strategic analysis ...

Analysis of the Global In Vitro Diagnostics Market

Analysis of the Global In Vitro Diagnostics Market

  • $ 10 000
  • Industry report
  • July 2014
  • by Frost & Sullivan

Slowing US and European Markets Demand Alignment with Global Market Needs Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of ...

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

Chemical and Physical Analysis Equipment Markets in Asia to 2018 - Market Size, Trends, and Forecasts

  • $ 7 302
  • Industry report
  • August 2014
  • by Global Research & Data Services

This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for chemical and physical analysis equipment in different Asian countries. ...

Global Immunoassay Systems Market

September 2014 $ 4 950

Global Cholesterol Testing Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.